ACRS · ISSUER CIK 1557746
Aclaris Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Aclaris Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 4, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 202617:03 | Aug 1, 2026 | ACRS | Chief Scientific Officer | M · Exercise | — | +36,375 | 36,375 | New | — | ||
| Aug 4, 202617:03 | Aug 1, 2026 | ACRS | Chief Scientific Officer | F · Tax | $5.20 | −12,385 | 23,990 | -34% | $64K |